Prevention With Ismigen of RTIs in Kids

Clinical trial NCT07578012 · RECRUITING

Trial details

NCT number: NCT07578012
Sponsor: Lallemand Pharma AG
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Respiratory Tract Infections (RTI)Healthy Children

Start date: 2026-06-01
Primary completion: 2027-03-01
Enrollment: 224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.